Neodynamics
0.902 SEK +0.22%HC Andersen Capital has previously received payment from Neodynamics for a Digital IR/Corporate Visibility agreement. This means that there may be paid material that is not updated. See disclaimer.
7 investors are following this company
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Revenue
320K
EBIT %
-28,425 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
NEOD
Daily low / high price
0.9 / 0.95
SEK
Market cap
29.42M SEK
Turnover
7.58K SEK
Volume
8.3K
Analyst
Claus Thestrup
CEO, Sweden
Latest videos
Financial calendar
Interim report
2024-08-20
Interim report
2024-11-19
Annual report
2025-02-17
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gryningskust Holding AB | 32.9 % | 32.9 % |
Rentability Sweden AB | 4.0 % | 4.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
NeoDynamics aktie avnoteras från Nasdaq First North
NeoDynamics applies for delisting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools